期刊文献+

艾滋病肺部机会性感染 被引量:9

Pulmonary opportunistic infection in AIDS
下载PDF
导出
摘要 肺是艾滋病(AIDS)相关机会性感染(OI)常见部位,有很高的发病率和死亡率。AIDS肺部OI的病原谱广泛,包括细菌、分枝杆菌、真菌、病毒及寄生虫等,但最常见的还是细菌、分枝杆菌和真菌。其临床表现及诊治方面都存在一定的特点。本文对AIDS肺部OI相关特征进行综述,希望对读者有益。 Pulmonary is a common target organ of opportunistic infection (OI) in acquired immune deficiency syndrome (AIDS), with a high incidence and mortality. The pathogenic spectrum of the pulmonary OI in AIDS is widespread, in- cluding bacteria, mycobacteria, fungi, viruses and parasites, and bacterial fungi, but the most common bacteria are bacterial, mycobacteria and fungi. There are certain characteristics in the clinical manifestation and the diagnosis and treatment. In this paper, the related characteristics of pulmonary OI in AIDS a reviewed, and hope is beneficial to the reader.
出处 《中国医药导报》 CAS 2018年第4期31-34,共4页 China Medical Herald
基金 国家自然科学基金资助项目(81571178 81371399)
关键词 人免疫缺陷病毒 艾滋病 机会性感染 细菌性肺炎 肺结核 肺孢子菌肺炎 HIV Acquired immune deficiency syndrome Opportunistic infection Bacterial pneumonia Pulmonary tuberculosis Pneumocystis pneumonia
  • 相关文献

参考文献3

二级参考文献85

  • 1胡志亮,池云,魏洪霞,杨永峰,成骢,程健,王华利,许传军.艾滋病合并隐球菌病患者的肺部影像学特征[J].中华临床感染病杂志,2013,6(4):237-240. 被引量:9
  • 2World Health Organization. Global tuberculosis report 2015 [ M].Geneva:World Health Organization, 2015 : 1-30.
  • 3World Health Organization. Guidelines on the management oflatent tuberculosis infection [ M ]. Geneva : World HealthOrganization, 2015 : 13-20.
  • 4Chong GY, Xin S, Ying P,et al. Transmission of tuberculosis inChina: a population-based molecular epidemiology study[ J]. ClinInfec Dis,2015,61(2) :219-227. doi: 10.1093/cid/civ255.
  • 5World Health Organization. Same-day diagnosis of tuberculosis bymicroscopy : policy statement [ M ]. Geneva : World HealthOrganization, 2011.
  • 6World Health Organization. Implementing tuberculosis diagnostics.Policy framework[ M]. Geneva: World Health Organization,2015.
  • 7World Health Organization. The use of bedaquiline in the treatmentof multidrug-resistant tuberculosis Interim policy guidance [ M ].Geneva : World Health Organization, 2013.
  • 8World Health Organization. The use of delamanid in the treatmentof multidrug-resistant tuberculosis. Interim policy guidance [ M ].Geneva : World Health Organization, 2014.
  • 9Esposito S, Bianchini S, Blasi F. Bedaquiline and delamanid intuberculosis [ J ] . Expert Opin Pharmacother, 2015 , 16 ( 15 ):2319-2330.
  • 10Szumowski JD,Lynch JB. Profile of delamanid for the treatment ofmultidrug-resistant tuberculosis [ J ]. Drug Des Devel Ther, 2015 ,9:677-682.

共引文献665

同被引文献147

引证文献9

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部